Literature DB >> 20524111

Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage.

M S Convento1, E Pessoa, M A Dalboni, F T Borges, N Schor.   

Abstract

Hyperuricemia is associated with cardiovascular and renal diseases, as glomerulosclerosis. Noncrystalline uric acid induces deleterious effects on endothelial and vascular smooth muscle cells. In the present study, we analyzed the damage induced by UA on human mesangial cells (HMC), the potential mechanism involved in this injury, and its consequences during infection. HMC were exposed to noncrystalline UA (8 mg/dl) and/or lipopolysaccharide (LPS, 100 μg/ml) for 24 h. In the experiments of cellular viability, HMC were exposed to 8-50 mg/dl of UA. Necrosis was assessed by acridine orange and ethidium bromide. Reactive oxygen species (ROS) were analyzed by 2',7'-dichlorofluorescein. Prostaglandin E2 (PGE2) was evaluated by ELISA. Cyclooxygenase 2 (COX-2) expression was assessed by real-time PCR. UA induced necrosis only at supraphysiological concentrations. Nevertheless, it significantly increased ROS production at 8 mg/dl. LPS increased necrosis and ROS production. Interestingly, the association between UA and LPS decreased ROS and necrosis. UA associated or not with LPS induced COX-2 expression and PGE2 increases in HMC. Results suggest that UA has pro- and anti-oxidant effects in HMC. During infections, it acts like scavenger increasing cellular viability, but alone it can induce ROS production and cellular death in higher concentrations. Additionally, UA has direct pro-inflammatory effects inducing COX-2 expression and PGE2 synthesis. It is concluded that elevated concentrations of uric acid potentially contributes to glomerular damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524111     DOI: 10.1007/s00240-010-0282-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  THE RENAL LESION IN GOUT.

Authors:  H C GONICK; M E RUBINI; I O GLEASON; S C SOMMERS
Journal:  Ann Intern Med       Date:  1965-04       Impact factor: 25.391

3.  Association between serum uric acid level and components of the metabolic syndrome.

Authors:  Shi-Dou Lin; Dong-Hwa Tsai; Shang-Ren Hsu
Journal:  J Chin Med Assoc       Date:  2006-11       Impact factor: 2.743

4.  Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress.

Authors:  Christine Gersch; Sergiu P Palii; Witcha Imaram; Kyung Mee Kim; S Ananth Karumanchi; Alexander Angerhofer; Richard J Johnson; George N Henderson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-02       Impact factor: 1.381

5.  Chemokine and chemokine receptor expression in a novel human mesangial cell line.

Authors:  B Banas; B Luckow; M Möller; C Klier; P J Nelson; E Schadde; M Brigl; D Halevy; H Holthöfer; B Reinhart; D Schlöndorff
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

6.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

7.  Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries.

Authors:  J V Selby; G D Friedman; C P Quesenberry
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

8.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

9.  Uric acid: the oxidant-antioxidant paradox.

Authors:  Yuri Y Sautin; Richard J Johnson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-06       Impact factor: 1.381

10.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  9 in total

Review 1.  Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.

Authors:  Ye-Fang Zhang; Fan He; Hong-Hui Ding; Wei Dai; Qian Zhang; Hong Luan; Yong-Man Lv; Hong-Bing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

2.  Evidence for the effect of soluble uric acid in augmenting endoplasmic reticulum stress markers in human peripheral blood mononuclear cells.

Authors:  Reyhane Ebrahimi; Parvin Pasalar; Hajar Shokri; Maryam Shabani; Solaleh Emamgholipour
Journal:  J Physiol Biochem       Date:  2022-01-05       Impact factor: 4.158

Review 3.  Physiological functions and pathogenic potential of uric acid: A review.

Authors:  Rashika El Ridi; Hatem Tallima
Journal:  J Adv Res       Date:  2017-03-14       Impact factor: 10.479

4.  COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation.

Authors:  Shuzhen Li; Zhenzhen Sun; Yue Zhang; Yuan Ruan; Qiuxia Chen; Wei Gong; Jing Yu; Weiwei Xia; John Ci-Jiang He; Songming Huang; Aihua Zhang; Guixia Ding; Zhanjun Jia
Journal:  Oncotarget       Date:  2017-02-07

Review 5.  Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.

Authors:  Hong-Yong Su; Chen Yang; Dong Liang; Hua-Feng Liu
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

6.  Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome.

Authors:  Hailong Zhang; Yuting Ma; Run Cao; Guanli Wang; Shaowei Li; Yue Cao; Hao Zhang; Meichen Liu; Guangchao Liu; Jun Zhang; Shulian Li; Yaohui Wang; Yuanfang Ma
Journal:  J Cell Mol Med       Date:  2020-06-18       Impact factor: 5.310

Review 7.  The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation.

Authors:  Yawen Deng; Fei Liu; Xiaolei Yang; Yunlong Xia
Journal:  Front Cardiovasc Med       Date:  2021-02-26

8.  Is hyperuricemia an independent prognostic factor for IgA nephropathy: a systematic review and meta-analysis of observational cohort studies.

Authors:  Kang Zhang; Long Tang; Shang-Shang Jiang; Yue-Fen Wang; Yuan Meng; Meng-di Wang; Fang-Qiang Cui; Zhen Cai; Wen-Jing Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

9.  The association of urinary prostaglandins with uric acid in hyperuricemia patients.

Authors:  Huagang Lin; Ying Xu; Yuqi Zheng; Deping Wu; Zhibin Ye; Jing Xiao
Journal:  BMC Nephrol       Date:  2022-09-03       Impact factor: 2.585

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.